Transient expression of serotonin 5-HT4 receptors in the mouse developing thalamocortical projections

Developmental Neurobiology

Volumn 70, Issue 3, 2010, Pages 165-181

  Slaten, Erin R ^a   Hernandez, Melissa C ^a   Albay III, Ricardo ^a   Lavian, Rachel ^a   Janušonis, Skirmantas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 HT4; 5 hydroxytryptamine (5 HT, serotonin); Cerebral cortex; Development; Thalamocortical

Indexed keywords

SEROTONIN 5 RECEPTOR; SEROTONIN 5HT4 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; EMBRYO DEVELOPMENT; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THALAMOCORTICAL TRACT;

ANIMALS; AXONS; CEREBRAL CORTEX; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED STRAINS; NEURAL PATHWAYS; NEURONAL TRACT-TRACERS; NEURONS; PROSENCEPHALON; QUANTUM DOTS; RECEPTORS, SEROTONIN, 5-HT4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THALAMUS;

EID: 73949150053     PISSN: 19328451     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/dneu.20775     Document Type: Article

References (80)

1. Albay R, Chen A, Anderson GM, Tatevosyan M, Janusonis S. 2009. Relationships among body mass, brain size, gut length, and blood tryptophan and serotonin in young wild-type mice. BMC Physiol 9:4.
2. Amisten S, Braun OO, Bengtsson A, Erlinge D. 2008. Gene expression profiling for the identification of G-protein coupled receptors in human platelets. Thromb Res 122:47-57.
3. Anderson GM. 2002. Genetics of childhood disorders: XLV. Autism, part 4: Serotonin in autism. J Am Acad Child Adolesc Psychiatry 41:1513-1516.
4. Anderson GM, Horne WC, Chatterjee D, Cohen DJ. 1990. The hyperserotonemia of autism. Ann NY Acad Sci 600:331-340.
5. Bach T, Syversveen T, Kvingedal AM, Krobert KA, Brattelid T, Kaumann AJ, Levy FO. 2001. 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle. Naunyn Schmiedebergs Arch Pharmacol 363:146-160.
6. Baranek GT, Boyd BA, Poe MD, David FJ, Watson LR. 2007. Hyperresponsive sensory patterns in young children with autism, developmental delay, and typical development. Am J Ment Retard 112:233-245.
7. 4 receptor signalling. EMBO J 28:2706-2718.
8. Barthet G, Framery B, Gaven F, Pellissier L, Reiter E, Claeysen S, Bockaert J, et al. 2007. 5-Hydroxytryptamine 4 receptor activation of the extracellular signalregulated kinase pathway depends on Src activation but not on G protein or β-arrestin signaling. Mol Biol Cell 18:1979-1991.
9. Barthet G, Gaven F, Framery B, Shinjo K, Nakamura T, Claeysen S, Bockaert J, et al. 2005. Uncoupling and endocytosis of 5-hydroxytryptamine 4 receptors. Distinct molecular events with different GRK2 requirements. J Biol Chem 280:27924-27934.
10. Berthouze M, Ayoub M, Russo O, Rivail L, Sicsic S, Fischmeister R, Berque-Bestel I, et al. 2005. Constitutive dimerization of human serotonin 5-HT4 receptors in living cells. FEBS Lett 579:2973-2980.
11. Berthouze M, Rivail L, Lucas A, Ayoub MA, Russo O, Sicsic S, Fischmeister R, et al. 2007. Two transmembrane Cys residues are involved in 5-HT4 receptor dimerization. Biochem Biophys Res Commun 356:642-647.
12. Besag FM. 2009. The relationship between epilepsy and autism: A continuing debate. Acta Paediatr 98:618-620.
13. Bockaert J, Claeysen S, Becamel C, Dumuis A, Marin P. 2006. Neuronal 5-HT metabotropic receptors: Fine-tuning of their structure, signaling, and roles in synaptic modulation. Cell Tissue Res 326:553-572.
14. Bockaert J, Claeysen S, Compan V, Dumuis A. 2004. 5-HT4 receptors. Curr Drug Targets CNS Neurol Disord 3:39-51.
15. 1 serotonin receptor subtypes during fetal and early postnatal mouse forebrain development. Neuroscience 141:781-794.
16. Bonnin A, Torii M, Wang L, Rakic P, Levitt P. 2007. Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat Neurosci 10:588-597.
17. Bruning G, Liangos O, Baumgarten HG. 1997. Prenatal development of the serotonin transporter in mouse brain. Cell Tissue Res 289:211-221.
18. Catalano SM, Robertson RT, Killackey HP. 1991. Early ingrowth of thalamocortical afferents to the neocortex of the prenatal rat. Proc Natl Acad Sci USA 88:2999-3003.
19. Claeysen S, Sebben M, Becamel C, Bockaert J, Dumuis A. 1999. Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: Role of the C-terminal intracellular domain. Mol Pharmacol 55:910-920.
20. Compan V, Zhou M, Grailhe R, Gazzara RA, Martin R, Gingrich J, Dumuis A, et al. 2004. Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice. J Neurosci 24:412-419.
21. 4 receptor knock-out mouse. Eur J Neurosci 24:1053-1062.
22. 4 receptor splice variants including a functional homofusion variant. Physiol Genomics 34:22-33.
23. Donovan SL, Mamounas LA, Andrews AM, Blue ME, McCasland JS. 2002. GAP-43 is critical for normal development of the serotonergic innervation in forebrain. J Neurosci 22:3543-3552.
24. Ghosh A, Shatz CJ. 1992. Pathfinding and target selection by developing geniculocortical axons. J Neurosci 12:39-55.
25. Giepmans BN, Deerinck TJ, Smarr BL, Jones YZ, Ellisman MH. 2005. Correlated light and electron microscopic imaging of multiple endogenous proteins using quantum dots. Nat Methods 2:743-749.
26. Gilger MA, Redel CA. 2009. Autism and the gut. Pediatrics 124:796-798.
27. Gomes E, Pedroso FS, Wagner MB. 2008. Auditory hypersensitivity in the autistic spectrum disorder. Pro Fono 20:279-284.
28. Hajos M, Richards CD, Szekely AD, Sharp T. 1998. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 87:95-108.
29. Hiroi T, Hayashi-Kobayashi N, Nagumo S, Ino M, Okawa Y, Aoba A, Matsui H. 2001. Identification and characterization of the human serotonin-4 receptor gene promoter. Biochem Biophys Res Commun 289:337-344.
30. Hoerder-Suabedissen A, Paulsen O, Molnar Z. 2008. Thalamocortical maturation in mice is influenced by body weight. J Comp Neurol 511:415-420.
31. Ivgy-May N, Tamir H, Gershon MD. 1994. Synaptic properties of serotonergic growth cones in developing rat brain. J Neurosci 14:1011-1029.
32. Jakeman LB, To ZP, Eglen RM, Wong EH, Bonhaus DW. 1994. Quantitative autoradiography of 5-HT4 receptors in brains of three species using two structurally distinct radioligands, [3H]GR113808 and [3H]BIMU-1. Neuropharmacology 33:1027-1038.
33. Janusonis S. 2008. Origin of the blood hyperserotonemia of autism. Theor Biol Med Model 5:10.
34. Janusonis S, Anderson GM, Shifrovich I, Rakic P. 2006. Ontogeny of brain and blood serotonin levels in 5-HT1A receptor knockout mice: Potential relevance to the neurobiology of autism. J Neurochem 99:1019-1031.
35. Janusonis S, Gluncic V, Rakic P. 2004. Early serotonergic projections to Cajal-Retzius cells: Relevance for cortical development. J Neurosci 24:1652-1659.
36. Kamel R, Garcia S, Lezoualc'h F, Fischmeister R, Muller S, Hoebek J, Eftekhari P. 2007. Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT4 receptor and its consequences in early BALB/c mouse embryonic development. BMC Dev Biol 7:34.
37. Kaumann AJ, Levy FO. 2006. 5-Hydroxytryptamine receptors in the human cardiovascular system. Pharmacol Ther 111:674-706.
38. Kornum BR, Lind NM, Gillings N, Marner L, Andersen F, Knudsen GM. 2009. Evaluation of the novel 5-HT4 receptor PET ligand [11C]SB207145 in the Gottingen minipig. J Cereb Blood Flow Metab 29:186-196.
39. Kostovic I, Rakic P. 1990. Developmental history of the transient subplate zone in the visual and somatosensory cortex of the macaque monkey and human brain. J Comp Neurol 297:441-470.
40. Lazic SE. 2008. Why we should use simpler models if the data allow this: Relevance for ANOVA designs in experimental biology. BMC Physiol 8:16.
41. Lebrand C, Cases O, Adelbrecht C, Doye A, Alvarez C, El MS, Seif I, et al. 1996. Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 17:823-835.
42. Lebrand C, Cases O, Wehrle R, Blakely RD, Edwards RH, Gaspar P. 1998. Transient developmental expression of monoamine transporters in the rodent forebrain. J Comp Neurol 401:506-524.
43. Lebrand C, Gaspar P, Nicolas D, Hornung JP. 2006. Transitory uptake of serotonin in the developing sensory pathways of the common marmoset. J Comp Neurol 499:677-689.
44. Lezoualc'h F, Steplewski K, Sartiani L, Mugelli A, Fischmeister R, Bril A. 2007. Quantitative mRNA analysis of serotonin 5-HT4 receptor isoforms, calcium handling proteins and ion channels in human atrial fibrillation. Biochem Biophys Res Commun 357:218-224.
45. Lidov HG, Molliver ME. 1982. An immunohistochemical study of serotonin neuron development in the rat: Ascending pathways and terminal fields. Brain Res Bull 8:389-430.
46. Liu M, Geddis MS, Wen Y, Setlik W, Gershon MD. 2005. Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am J Physiol Gastrointest Liver Physiol 289:G1148-G1163.
47. Liu MT, Kuan YH, Wang J, Hen R, Gershon MD. 2009. 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci 29:9683-9699.
48. 4 agonists. Biol Psychiatry 57:918-925.
49. Mader R, Kocher T, Haier J, Wieczorek G, Pfannkuche HJ, Ito M. 2006. Investigation of serotonin type 4 receptor expression in human and non-human primate gastrointestinal samples. Eur J Gastroenterol Hepatol 18:945-950.
50. 4 receptor mRNA. Biochem J 387 (Pt 2):463-471.
51. 4(a) receptors avert opioid-induced breathing depression without loss of analgesia. Science 301:226-229.
52. Manzke T, Preusse S, Hulsmann S, Richter DW. 2008. Developmental changes of serotonin 4(a) receptor expression in the rat pre-Bötzinger complex. J Comp Neurol 506:775-790.
53. Medhurst AD, Lezoualc'h F, Fischmeister R, Middlemiss DN, Sanger GJ. 2001. Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR. Brain Res Mol Brain Res 90:125-134.
54. Meijer HA, Thomas AA. 2002. Control of eukaryotic protein synthesis by upstream open reading frames in the 50′-untranslated region of an mRNA. Biochem J 367 (Pt 1):1-11.
55. Millan MJ. 2002. Descending control of pain. Prog Neurobiol 66:355-474.
56. Millan MJ, Marin P, Bockaert J, Mannoury la CC. 2008. Signaling at G-protein-coupled serotonin receptors: Recent advances and future research directions. Trends Pharmacol Sci 29:454-464.
57. 4 agonist, enhances memory and hippocampal acetylcholine efflux. Neuropharmacology 53:563-573.
58. Molnar Z, Adams R, Blakemore C. 1998. Mechanisms underlying the early establishment of thalamocortical connections in the rat. J Neurosci 18:5723-5745.
59. Molnar Z, Cordery P. 1999. Connections between cells of the internal capsule, thalamus, and cerebral cortex in embryonic rat. J Comp Neurol 413:1-25.
60. Mulder EJ, Anderson GM, Kema IP, de Bildt A, van Lang ND, den Boer JA, Minderaa RB. 2004. Platelet serotonin levels in pervasive developmental disorders and mental retardation: Diagnostic group differences, within-group distribution, and behavioral correlates. J Am Acad Child Adolesc Psychiatry 43:491-499.
61. Parga J, Rodriguez-Pallares J, Munoz A, Guerra MJ, Labandeira-Garcia JL. 2007. Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors. Dev Neurobiol 67:10-22.
62. Pellissier LP, Sallander J, Campillo M, Gaven F, Queffeulou E, Pillot M, Dumuis A, et al. 2009. Conformational toggle switches implicated in basal constitutive and agonist-induced activated states of 5-hydroxytryptamine-4 receptors. Mol Pharmacol 75:982-990.
63. Perez-Garcia G, Meneses A. 2008. Memory formation, amnesia, improved memory and reversed amnesia: 5-HT role. Behav Brain Res 195:17-29.
64. Peters A, Palay SL, Webster HF. 1991. The Fine Structure of the Nervous System. New York, NY: Oxford University Press, 494 p.
65. Poole DP, Xu B, Koh SL, Hunne B, Coupar IM, Irving HR, Shinjo K, et al. 2006. Identification of neurons that express 5-hydroxytryptamine4 receptors in intestine. Cell Tissue Res 325:413-422.
66. Rakic P. 1977. Prenatal development of the visual system in rhesus monkey. Philos Trans R Soc Lond B Biol Sci 278:245-260.
67. 4b receptor antibodies. Eur J Pharmacol 604:1-11.
68. Resch-Genger U, Grabolle M, Cavaliere-Jaricot S, Nitschke R, Nann T. 2008. Quantum dots versus organic dyes as fluorescent labels. Nat Methods 5:763-775.
69. Schworer H, Ramadori G. 1998. Autoreceptors can modulate 5-hydroxytryptamine release from porcine and human small intestine in vitro. Naunyn Schmiedebergs Arch Pharmacol 357:548-552.
70. 4 receptor expression and effects of tegaserod on human platelet aggregation in vitro. Am J Ther, in press.
71. Sherman SM, Guillery RW. 2006. Exploring the Thalamus and its Role in Cortical Function. Cambridge, MA: The MIT Press, 484 p.
72. Sosinsky GE, Giepmans BN, Deerinck TJ, Gaietta GM, Ellisman MH. 2007. Markers for correlated light and electron microscopy. Methods Cell Biol 79:575-591.
73. Ullmer C, Engels P, Abdel'Al S, Lubbert H. 1996. Distribution of 5-HT4 receptor mRNA in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 354:210-212.
74. Verney C, Lebrand C, Gaspar P. 2002. Changing distribution of monoaminergic markers in the developing human cerebral cortex with special emphasis on the serotonin transporter. Anat Rec 267:87-93.
75. 4 receptor mRNA in rat brain by in situ hybridization histochemistry. Brain Res Mol Brain Res 43:356-360.
76. 4 receptors and their mRNAs in rat and guinea pig brain: Distribution and effects of neurotoxic lesions. J Comp Neurol 484:418-439.
77. Waeber C, Sebben M, Bockaert J, Dumuis A. 1996. Regional distribution and ontogeny of 5-HT4 binding sites in rat brain. Behav Brain Res 73:259-262.
78. Waeber C, Sebben M, Grossman C, Javoy-Agid F, Bockaert J, Dumuis A. 1993. [3H]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain. Neuroreport 4:1239-1242.
79. 4 binding sites in rodent brain. Neuropharmacology 33:527-541.
80. Wallace JA, Lauder JM. 1983. Development of the serotonergic system in the rat embryo: An immunocytochemical study. Brain Res Bull 10:459-479.